El interés en corto de SunLink Health Systems da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de SunLink Health Systems. Los datos de interés en corto se actualizan cada dos semanas.

SunLink Health Systems (AMEX:SSY) Bolsa, Informe de interés en corto

SunLink Health Systems

SunLink Health Systems Inc is engaged in providing retail pharmacy services. The company operates its business through segments namely the Healthcare Services segment and Pharmacy segment. The Healthcare Services segment includes subsidiaries that own and operate licensed-bed, acute care hospitals, which includes bed geriatric psychology unit, and nursing home; own medical buildings, which are leased to unaffiliated healthcare providers, and adjacent vacant land; and provides information technology to outside customers. The Pharmacy segment, which is the key revenue generator is composed of retail pharmacy products and services that are conducted in rural markets; institutional pharmacy services; pharmacy services; and durable medical equipment.

<h3>Gainers</h3>
<ul>
<li>Calidi Biotherapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CLDI#AMEX">CLDI</a>) shares moved upwards by 24.9% to $0.42 during Tuesday's after-market session. The market value of their outstanding shares is at $7.6 million. </li>
<li>SunLink Health Systems (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SSY#AMEX">SSY</a>) shares increased by 10.0% to $1.1. The company's market cap stands at $7.1 million. </li>
<li>ProKidney (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PROK#NASDAQ">PROK</a>) shares increased by 9.91% to $4.1. The market value of their outstanding shares is at $78.5 million. </li>
<li>Inotiv (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NOTV#NASDAQ">NOTV</a>) stock rose 9.9% to $2.33. The market value of their outstanding shares is at $70.4 million. </li>
<li>Co-Diagnostics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CODX#NASDAQ">CODX</a>) shares rose 7.03% to $0.3. The company's market cap stands at $8.7 million. </li>
<li>Wellgistics Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WGRX#NASDAQ">WGRX</a>) stock moved upwards by 5.17% to $0.93. The company's market cap stands at $67.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>RxSight (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXST#NASDAQ">RXST</a>) stock declined by 33.2% to $8.55 during Tuesday's after-market session. The company's market cap stands at $505.1 million. </li>
<li>Entero Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENTO#NASDAQ">ENTO</a>) stock decreased by 18.89% to $0.43. The company's market cap stands at $1.8 million. </li>
<li>Gelteq (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GELS#NASDAQ">GELS</a>) stock declined by 6.85% to $1.77. The market value of their outstanding shares is at $16.1 million. </li>
<li>Rockwell Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMTI#NASDAQ">RMTI</a>) stock fell 6.57% to $0.87. The company's market cap stands at $27.1 million. </li>
<li>Universe Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPC#NASDAQ">UPC</a>) stock fell 6.42% to $3.5. The market value of their outstanding shares is at $54.9 million. </li>
<li>Windtree Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WINT#NASDAQ">WINT</a>) stock fell 5.8% to $0.74. The company's market cap stands at $2.9 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

CLDI

CODX

ENTO

GELS

NOTV

PROK

RMTI

RXST

WGRX

WINT

12 Health Care Stocks Moving In Tuesday's After-Market Session

News

Reported Earlier, SunLink Health Systems Hit With NYSE Deficiency Notice For Failing To Hold Annual Shareholder Meeting For Fiscal Year Ending June 30, 2025

<h3>Gainers</h3>
<ul>
<li>Catheter Precision (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/VTAK#AMEX">VTAK</a>) shares moved upwards by 216.8% to $0.72 during Wednesday's pre-market session. The market value of their outstanding shares is at $7.9 million. </li>
<li>Helius Medical Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSDT#NASDAQ">HSDT</a>) shares rose 104.73% to $1.73. </li>
<li>Vaxart (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VXRT#NASDAQ">VXRT</a>) shares rose 78.26% to $0.7. The market value of their outstanding shares is at $159.8 million. </li>
<li>Kazia Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KZIA#NASDAQ">KZIA</a>) stock moved upwards by 36.43% to $7.17. The market value of their outstanding shares is at $40.0 million. </li>
<li>NuCana (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCNA#NASDAQ">NCNA</a>) shares moved upwards by 30.87% to $0.19. The market value of their outstanding shares is at $1.1 million. </li>
<li>SunLink Health Systems (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SSY#AMEX">SSY</a>) shares moved upwards by 17.17% to $1.16. The market value of their outstanding shares is at $8.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>CARISMA Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CARM#NASDAQ">CARM</a>) stock fell 33.3% to $0.74 during Wednesday's pre-market session. The company's market cap stands at $30.9 million. </li>
<li>Gelteq (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GELS#NASDAQ">GELS</a>) stock declined by 17.29% to $2.44. The company's market cap stands at $23.0 million. </li>
<li>Windtree Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WINT#NASDAQ">WINT</a>) shares declined by 13.07% to $0.7. The market value of their outstanding shares is at $2.5 million. </li>
<li>Klotho Neurosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLTO#NASDAQ">KLTO</a>) stock decreased by 12.94% to $1.75. The company's market cap stands at $56.8 million. </li>
<li>Tempest Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPST#NASDAQ">TPST</a>) shares fell 12.84% to $7.74. The market value of their outstanding shares is at $28.5 million. </li>
<li>Cabaletta Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CABA#NASDAQ">CABA</a>) shares declined by 10.64% to $2.1. The company's market cap stands at $106.5 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CABA

CARM

HSDT

KLTO

KZIA

NCNA

Tempest Therapeutics, Inc. - Common Stock

TPST

VTAK

VXRT

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Catheter Precision (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/VTAK#AMEX">VTAK</a>) stock increased by 97.3% to $0.45 during Tuesday's after-market session. The company's market cap stands at $4.9 million. </li>
<li>Serina Therapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SER#AMEX">SER</a>) stock moved upwards by 23.08% to $7.25. The company's market cap stands at $72.2 million. </li>
<li>Nuwellis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUWE#NASDAQ">NUWE</a>) stock rose 11.08% to $0.26. The company's market cap stands at $1.1 million. </li>
<li>Windtree Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WINT#NASDAQ">WINT</a>) stock increased by 10.12% to $0.87. The company's market cap stands at $3.1 million. </li>
<li>Imunon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMNN#NASDAQ">IMNN</a>) stock moved upwards by 7.97% to $1.75. The market value of their outstanding shares is at $30.6 million. </li>
<li>SunLink Health Systems (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SSY#AMEX">SSY</a>) shares moved upwards by 7.07% to $1.06. The market value of their outstanding shares is at $7.4 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>NuCana (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCNA#NASDAQ">NCNA</a>) shares fell 18.4% to $0.12 during Tuesday's after-market session. </li>
<li>Gelteq (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GELS#NASDAQ">GELS</a>) shares decreased by 14.92% to $2.51. The market value of their outstanding shares is at $23.6 million. </li>
<li>CARISMA Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CARM#NASDAQ">CARM</a>) shares declined by 14.08% to $0.93. The market value of their outstanding shares is at $38.7 million. </li>
<li>Abpro Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABP#NASDAQ">ABP</a>) stock decreased by 9.88% to $0.25. The market value of their outstanding shares is at $15.1 million. </li>
<li>Citius Oncology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTOR#NASDAQ">CTOR</a>) stock decreased by 6.26% to $1.2. The company's market cap stands at $85.8 million. </li>
<li>Inogen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INGN#NASDAQ">INGN</a>) shares declined by 5.52% to $6.25. The company's market cap stands at $168.1 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CTOR

IMNN

INGN

NUWE

<h3>Gainers</h3>
<ul>
<li>ModivCare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MODV#NASDAQ">MODV</a>) shares increased by 58.0% to $2.07 during Thursday's after-market session. The company's market cap stands at $29.7 million. </li>
<li>SunLink Health Systems (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SSY#AMEX">SSY</a>) shares increased by 22.86% to $1.1. The market value of their outstanding shares is at $7.7 million. </li>
<li>Liminatus Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIMN#NASDAQ">LIMN</a>) shares moved upwards by 13.4% to $5.92. The market value of their outstanding shares is at $158.1 million. </li>
<li>Elevation Oncology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELEV#NASDAQ">ELEV</a>) shares moved upwards by 7.8% to $0.33. The company's market cap stands at $19.5 million. </li>
<li>SAB Biotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SABS#NASDAQ">SABS</a>) stock increased by 7.39% to $1.88. The market value of their outstanding shares is at $17.4 million. </li>
<li>Tango Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNGX#NASDAQ">TNGX</a>) stock moved upwards by 7.29% to $2.5. The market value of their outstanding shares is at $270.9 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Femasys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FEMY#NASDAQ">FEMY</a>) shares declined by 14.5% to $0.87 during Thursday's after-market session. The company's market cap stands at $23.7 million. </li>
<li>Nautilus Biotechnology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAUT#NASDAQ">NAUT</a>) shares fell 8.71% to $0.73. The market value of their outstanding shares is at $91.6 million. </li>
<li>Indaptus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INDP#NASDAQ">INDP</a>) stock declined by 8.16% to $0.37. The market value of their outstanding shares is at $5.8 million. </li>
<li>bioAffinity Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIAF#NASDAQ">BIAF</a>) shares decreased by 7.93% to $0.31. The market value of their outstanding shares is at $8.4 million. </li>
<li>Healthcare Triangle (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCTI#NASDAQ">HCTI</a>) stock decreased by 7.7% to $0.01. The market value of their outstanding shares is at $3.4 million. </li>
<li>Nexalin Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXL#NASDAQ">NXL</a>) shares declined by 7.56% to $1.1. The company's market cap stands at $18.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BIAF

ELEV

FEMY

HCTI

INDP

LIMN

MODV

NAUT

SABS

TNGX

12 Health Care Stocks Moving In Thursday's After-Market Session

SunLink Health Systems (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SSY#AMEX">SSY</a>) reported quarterly losses of $(0.10) per share. This is a 50 percent increase over losses of $(0.20) per share from the same period last year. The company reported $7.32 million in sales this quarter. This is a 1.86 percent decrease over sales of $7.46 million the same period last year.

Earnings

SunLink Health Systems Q3 EPS $(0.10) Up From $(0.20) YoY, Sales $7.32M Down From $7.46M YoY

Atlanta, GA, April 15, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. ("Regional") (OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/RHEP#OTCQB">RHEP</a>) (OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/RHEPA#OTCQB">RHEPA</a>) and SunLink Health Systems, Inc. ("SunLink") (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSY#NYSE">SSY</a>) jointly announced today that they have entered into an amended and restated agreement and plan of merger (the "merger agreement"), pursuant to which SunLink will merge with and into Regional (the "merger") in exchange for the issuance of an aggregate of approximately 1,595,401 shares of Regional common stock and 1,408,121 shares of Regional's newly-authorized Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares (the "Regional Series D Preferred Stock") with an initial liquidation preference of $12.50 per share. The merger agreement has been approved by each company's board of directors and completion of the transaction remains subject to the receipt of the approvals of the shareholders of both Regional and SunLink, regulatory approvals and satisfaction of customary closing conditions.

RHEP

RHEPA

Sunlink To Merge With Regional Health Properties In Exchange For Regional Series D Preferred Stock With Initial Liquidation Preference Of $12.50/Shr

<h3>Gainers</h3>
<ul>
<li>Windtree Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WINT#NASDAQ">WINT</a>) stock increased by 39.2% to $2.06 during Monday's pre-market session. The market value of their outstanding shares is at $1.5 million. </li>
<li>Allarity Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALLR#NASDAQ">ALLR</a>) shares moved upwards by 20.2% to $1.19. The market value of their outstanding shares is at $5.2 million. </li>
<li>Capstone Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAPS#NASDAQ">CAPS</a>) stock rose 19.18% to $2.05. The market value of their outstanding shares is at $2.8 million. </li>
<li>Tharimmune (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/THAR#NASDAQ">THAR</a>) shares rose 17.94% to $1.7. The market value of their outstanding shares is at $3.2 million. </li>
<li>Regencell Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) shares increased by 17.7% to $69.01. The company's market cap stands at $898.0 million. </li>
<li>ProPhase Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRPH#NASDAQ">PRPH</a>) stock rose 16.54% to $0.36. The market value of their outstanding shares is at $10.8 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>23andMe Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ME#NASDAQ">ME</a>) stock declined by 44.1% to $1.0 during Monday's pre-market session. The market value of their outstanding shares is at $26.8 million. </li>
<li>Unity Biotechnology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UBX#NASDAQ">UBX</a>) shares decreased by 37.0% to $1.15. The market value of their outstanding shares is at $19.3 million. </li>
<li>TransCode Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNAZ#NASDAQ">RNAZ</a>) shares decreased by 32.6% to $0.75. </li>
<li>Impact BioMedical (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/IBO#AMEX">IBO</a>) stock declined by 13.92% to $4.27. The market value of their outstanding shares is at $49.1 million. </li>
<li>SunLink Health Systems (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SSY#AMEX">SSY</a>) shares decreased by 12.46% to $0.95. The market value of their outstanding shares is at $6.6 million. </li>
<li>Helius Medical Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSDT#NASDAQ">HSDT</a>) stock fell 10.89% to $0.38. The company's market cap stands at $1.4 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ALLR

CAPS

PRPH

RNAZ

THAR

12 Health Care Stocks Moving In Monday's Pre-Market Session

SunLink Health Systems Q2 EPS $(0.19) Down From $(0.44) YoY; Revenue $7.935M Down From $8.510M YoY

WIIM

Regional Health Properties shares are trading higher after the company announced an all-stock merger with SunLink Health Systems.

Regional Health Properties, Inc. (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/RHE#AMEX">RHE</a>) and SunLink Health Systems, Inc. (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SSY#AMEX">SSY</a>) shares traded higher after the companies disclosed a merger agreement.
As part of the deal, Regional Health Properties will issue 1.41 million shares of common stock and 1.41 million shares of newly authorized Series D 8% Cumulative Convertible Redeemable Preferred Stock.
Notably, for every five shares of SunLink common stock, Regional will issue one share of common stock and, subject to adjustments, one share of Series D Preferred Stock.
Post-merger, SunLink shareholders will own about 43% of the combined company.  The Series D Preferred Stock has a $10 liquidation preference and an 8% annual dividend, starting July 1, 2027. Each three shares of Series D Preferred Stock are convertible into one share of Regional common stock.
Upon shareholder approval, SunLink may pay a special dividend, subject to cash availability. No fractional shares will be issued.
Regional anticipates pre-tax cost synergies of $1 million by the end of its fiscal 2026. The transaction, unanimously approved by both companies&#8217; boards, is expected to close in spring 2025, pending customary conditions.
As of December 31, 2024, SunLink reported $17.6 million in total assets with no long-term debt.
Price Action: RHE shares are up 190.3% at $4.499 and, SSY shares rose 19.2% at $1.085 at the last check Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/42812603" target="_blank" rel="noreferrer noopener">Uber CFO Says Stock Undervalued, Initiates $1.5 Billion Accelerated Stock Buyback</a></li>
</ul>
Photo via Shutterstock.

Equities

Small Cap

SunLink Joins Forces With Regional Health Properties In All-Stock Deal: Shares Surge

CORRECTION: Regional And SunLink Announced Merger; SunLink To Merge Into Regional In Exchange For 1.41M Regional Common Shares And Series D Preferred Stock. SunLink Shareholders To Own 43% Of Combined Company

SunLink Health Systems (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SSY#AMEX">SSY</a>) reported quarterly losses of $(0.06) per share. This is unchanged from the same period last year. The company reported $7.92 million in sales this quarter. This is a 7.39 percent decrease over sales of $8.55 million the same period last year.

SunLink Health Systems Q1 EPS $(0.06), Same YoY, Sales $7.92M Down From $8.55M YoY

With U.S. stock futures trading slightly lower this morning on Friday, some of the stocks that may grab investor focus today are as follows:
<ul>
<li>Wall Street expects JPMorgan Chase &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>) to report quarterly earnings at $4.01 per share on revenue of $41.65 billion before the opening bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. JPMorgan shares fell 0.1% to $212.56 in after-hours trading.</li>
<li>SunLink Health Systems, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSY#NYSE">SSY</a>) announced the sale of its Trace regional hospital real estate for $2 million. SunLink Health shares gained 6% to $0.86 in after-hours trading.</li>
<li>Analysts are expecting Wells Fargo &amp; Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WFC#NYSE">WFC</a>) to post quarterly earnings at $1.28 per share on revenue of $20.41 billion. The company will release earnings before the markets open. Wells Fargo shares gained 0.1% to $57.80 in after-hours trading.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul>
<li>Before the markets open, Fastenal Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FAST#NASDAQ">FAST</a>) is projected to report quarterly earnings at 51 cents per share on revenue of $1.91 billion. Fastenal shares fell 0.6% to $69.60 in after-hours trading.</li>
<li>Analysts expect The Bank of New York Mellon Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BK#NYSE">BK</a>) to post quarterly earnings at $1.42 per share on revenue of $4.54 billion before the opening bell. Bank of New York Mellon shares gained 0.6% to $74.89 in after-hours trading.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41272079/top-2-health-care-stocks-that-are-ticking-portfolio-bombs">Top 2 Health Care Stocks That Are Ticking Portfolio Bombs</a></li>
</ul>
Photo courtesy: Shutterstock

Long Ideas

Pre-Market Outlook

Markets

Trading Ideas

FAST

JPMorgan, Wells Fargo And 3 Stocks To Watch Heading Into Friday

<h3>Gainers</h3>
<ul>
<li>NewGenIvf Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIVF#NASDAQ">NIVF</a>) shares rose 58.1% to $0.95 during Thursday's after-market session. The company's market cap stands at $9.6 million. </li>
<li>SunLink Health Systems (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SSY#AMEX">SSY</a>) shares increased by 17.13% to $0.95. The company's market cap stands at $6.6 million. </li>
<li>Akanda (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKAN#NASDAQ">AKAN</a>) shares increased by 5.55% to $1.14. The company's market cap stands at $3.2 million. </li>
<li>Butterfly Network (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BFLY#NYSE">BFLY</a>) shares moved upwards by 5.17% to $1.83. The market value of their outstanding shares is at $389.0 million. </li>
<li>Nurix Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NRIX#NASDAQ">NRIX</a>) shares moved upwards by 5.16% to $22.99. The market value of their outstanding shares is at $1.4 billion. </li>
<li>Kindly MD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KDLY#NASDAQ">KDLY</a>) shares moved upwards by 5.07% to $1.34. The market value of their outstanding shares is at $7.9 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Klotho Neurosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLTO#NASDAQ">KLTO</a>) stock fell 6.5% to $0.45 during Thursday's after-market session. The market value of their outstanding shares is at $9.5 million. </li>
<li>Phio Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHIO#NASDAQ">PHIO</a>) shares declined by 5.1% to $2.42. The market value of their outstanding shares is at $2.0 million. </li>
<li>Humana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUM#NYSE">HUM</a>) stock declined by 4.76% to $239.49. The market value of their outstanding shares is at $28.8 billion. </li>
<li>Processa Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCSA#NASDAQ">PCSA</a>) stock declined by 4.69% to $1.22. The market value of their outstanding shares is at $3.9 million. </li>
<li>Tango Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNGX#NASDAQ">TNGX</a>) shares fell 4.59% to $6.25. The market value of their outstanding shares is at $669.6 million. </li>
<li>Regencell Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) stock declined by 4.5% to $6.59. The company's market cap stands at $85.7 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AKAN

BFLY

KDLY

NIVF

NRIX

PCSA

PHIO

SunLink Health Systems shares are trading higher after the company announced the sale of its Trace regional hospital real estate for $2 million.

Asset Sales

SunLink Health Systems Sells Trace Regional Hospital Real Estate For $2M, Retains $1.93M Net Proceeds For Working Capital And Strategic Transaction Opportunities

Reported Earlier, SunLink Health Systems Q4 EPS $0.61 Up From $(0.20) YoY, Sales $7.91M Down From $8.01M YoY

<h3>Gainers</h3>
<ul>
<li>Concord Medical Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCM#NYSE">CCM</a>) shares moved upwards by 131.0% to $4.85 during Tuesday's after-market session. The company's market cap stands at $210.6 million. </li>
<li>Calidi Biotherapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CLDI#AMEX">CLDI</a>) stock increased by 4.26% to $0.21. The market value of their outstanding shares is at $10.8 million. </li>
<li>Anitra (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AZTR#AMEX">AZTR</a>) shares moved upwards by 2.69% to $0.18. The market value of their outstanding shares is at $5.0 million. </li>
<li>MAIA Biotechnology (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MAIA#AMEX">MAIA</a>) stock rose 0.79% to $3.79. The company's market cap stands at $82.7 million. </li>
<li>Emergent BioSolutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EBS#NYSE">EBS</a>) shares moved upwards by 0.53% to $5.59. The market value of their outstanding shares is at $292.9 million. </li>
<li>Asensus Surgical (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ASXC#AMEX">ASXC</a>) shares increased by 0.38% to $0.24. The market value of their outstanding shares is at $64.4 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>BiomX (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/PHGE#AMEX">PHGE</a>) stock fell 4.7% to $0.4 during Tuesday's after-market session. The market value of their outstanding shares is at $28.0 million. </li>
<li>SunLink Health Systems (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SSY#AMEX">SSY</a>) shares declined by 3.8% to $0.68. The company's market cap stands at $4.7 million. </li>
<li>Scorpius Holdings (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SCPX#AMEX">SCPX</a>) shares fell 3.55% to $0.12. The market value of their outstanding shares is at $11.8 million. </li>
<li>MultiPlan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPLN#NYSE">MPLN</a>) shares decreased by 1.19% to $0.47. The market value of their outstanding shares is at $300.1 million. </li>
<li>IGC Pharma (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/IGC#AMEX">IGC</a>) shares fell 0.97% to $0.47. The company's market cap stands at $35.4 million. </li>
<li>Nanoviricides (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/NNVC#AMEX">NNVC</a>) shares decreased by 0.78% to $2.4. The company's market cap stands at $28.3 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ASXC

AZTR

MAIA

MPLN

NNVC

PHGE

SCPX

SunLink Health Systems Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSY#NASDAQ">SSY</a>) shares are trading higher by 13.4% to $0.68 during Tuesday's session after the company late Monday announced that its subsidiary, Southern Health Corporation of Houston, has sold the Trace Extended Care &amp; Rehab senior care facility and related real estate in Houston, Mississippi <a href="https://www.benzinga.com/pressreleases/24/06/b39148432/sunlink-health-systems-inc-announces-sale-of-trace-extended-care-rehab">for around $7.1 million</a>. 
The net proceeds of about $6.5 million will be used for working capital and general corporate purposes. The sale is expected to result in a pre-tax gain of approximately $5.7 million in the fourth fiscal quarter ending June 30.&nbsp;
This sale aligns with SunLink&#8217;s strategy to position itself for a potential extraordinary transaction, such as a merger or consolidation, improve its operations, and consider selling non-performing assets. The company aims to find a strategic transaction that offers shareholders a chance for future value appreciation with acceptable risk.
See Also: <a href="https://www.benzinga.com/news/24/06/39148996/dave-portnoy-blasts-e-trade-amid-roaring-kitty-ban-considerations">Dave Portnoy Blasts E&#x2A;Trade Amid Roaring Kitty Ban Considerations</a>
<h1 class="wp-block-heading">How To Buy SSY Stock</h1>
By now you're likely curious about how to participate in the market for SunLink Health Systems &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of<a href="https://www.benzinga.com/money/best-stock-trading-platforms"> possible trading platforms here.</a> Many will allow you to buy ‘fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock, like Berkshire Hathaway, or Amazon.com, can cost thousands of dollars to own just one share. However, if you only want to invest a fraction of that, brokerages will allow you to do so.
In the the case of SunLink Health Systems, which is trading at $0.6 as of publishing time, $100 would buy you 166.67 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to ‘go short' a share of stock by lending you the shares to sell. The process of shorting a<a href="https://www.benzinga.com/money/how-to-short-a-stock"> stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, SSY has a 52-week high of $1.05 and a 52-week low of $0.53.

Why SunLink Health Systems (SSY) Stock Is Moving

Press Releases

SSY Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of SunLink Health Systems, Inc. Is Fair to Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SSY, FUBO, RHE, POAI on Behalf of Shareholders

$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of SunLink Health Systems, Inc. - SSY

SUNLINK HEALTH INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of SunLink Health Systems, Inc. - SSY

Legal

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates GETY, NARI, SSY on Behalf of Shareholders

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates MRNS, RHE, SSY, CTV on Behalf of Shareholders

SunLink Health Systems, Inc. Announces Fiscal 2025 Second Quarter Results

REGIONAL HEALTH PROPERTIES AND SUNLINK HEALTH SYSTEMS REVISE ALL-STOCK MERGER TRANSACTION

SunLink Health Systems, Inc. Announces Fiscal 2025 Third Quarter Results

SunLink Health Systems Announces That It Received a NYSE American LLC Notice Indicating That SunLink Has Fallen Below Certain NYSE American Continued Listing Standards

Comments

SunLink Health Systems

Interés en corto

SunLink Health Systems (AMEX:SSY) Bolsa, Informe de interés en corto

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL